SIREN : 444465736
SEQENS is a French company founded 23 years ago, specialized in the sector Activités des sièges sociaux. Based in ECULLY (69130), this company of category ETI shows in 2024 a revenue of 53.7 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 53 691 000 € | 43 181 000 € | 20 122 000 € | 18 627 000 € | 15 302 000 € | 11 483 € | 8 001 € | 8 297 000 € | 10 202 000 € |
| Net income | 119 528 000 € | -83 586 000 € | -112 892 000 € | -17 883 000 € | -9 896 000 € | -16 855 € | -2 876 € | 16 899 000 € | -16 183 000 € |
| EBITDA | 4 884 000 € | -1 362 000 € | -14 128 000 € | -14 643 000 € | -11 695 000 € | -11 295 € | -11 818 € | -20 145 000 € | -19 645 000 € |
| Net margin | 222.6% | -193.6% | -561.0% | -96.0% | -64.7% | -146.8% | -35.9% | 203.7% | -158.6% |
In 2024, SEQENS achieves revenue of 53.7 M€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +23.1%. Vs 2023, growth of +24% (43.2 M€ -> 53.7 M€). After deducting consumption (0 €), gross margin stands at 53.7 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 4.9 M€, representing 9.1% of revenue. Positive scissor effect: EBITDA margin improves by +12.3 pts, sign of improved operational efficiency. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 119.5 M€, i.e. 222.6% of revenue. This profit can be retained or distributed to shareholders.
53 691 000 €
53 691 000 €
4 884 000 €
6 579 000 €
119 528 000 €
9.1%
The debt ratio (= Financial debt / Equity x 100) stands at 4%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 73%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.3 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 221.7% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
4.428%
72.836%
221.732%
0.28
34.8%
In 2024, the debt ratio of SEQENS (4.43) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2024, the financial autonomy of SEQENS (72.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2024, the repayment capacity of SEQENS (0.28) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 38.84. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 1499.2x. Operating income very largely covers interest expenses: high safety margin.
38.838
1499.201
In 2024, the liquidity ratio of SEQENS (38.84) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2024, the interest coverage of SEQENS (1499.2x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 103 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 75 days. The company must finance 28 days of gap between collections and payments. WCR is negative (-1000 days): operations structurally generate cash. Notable WCR improvement over the period (-397%), freeing up cash.
-149 177 759 €
103 j
75 j
0 j
-1000 j
Based on 103 transactions of similar company sales in 2024, the value of SEQENS is estimated at 245 661 389 € (range 83 057 988€ - 644 637 492€). With an EBITDA of 4 884 000€, the sector multiple of 5.0x is applied. The price/revenue ratio is 0.38x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 103 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare SEQENS with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sièges sociaux
The revenue of SEQENS in 2024 is 53.7 M€.
Yes, SEQENS generated a net profit of 119.5 M€ in 2024.
The headquarters of SEQENS is located in ECULLY (69130), in the department Rhone.
The tax return of SEQENS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
SEQENS operates in the sector Activités des sièges sociaux (NAF code 70.10Z). See the 'Sector positioning' section above to compare the company with its competitors.